The flowcytometry-based immune profiling panel studies in J558 allograft syngeneic mouse models were performed at Medicilon. 

In vivo efficacy studies in J558 allograft models in combination with anti-mPD-1, anti-mPD-L1, and anti-mCTLA-4 antibodies were performed at Medicilon.

Reference